Immunosuppressant Drug Testing Controls and Calibrators
Thermo Scientific™ QMS™ Therapeutic Drug Monitoring (TDM) Calibrators
Accurately measure therapeutic drug levels in serum and plasma with Thermo Scientific™ QMS™ TDM Calibrators, offered in Levels A to F.
Thermo Scientific™ QMS™ Tacrolimus Immunoassays and Calibrators
Achieve excellent low-end precision and sensitivity with the Thermo Scientific™ QMS™ Tacrolimus Immunoassay.
Thermo Scientific™ QMS™ Everolimus Immunoassays, Calibrators and Controls
Obtain results you can count on for immunosuppressant drug monitoring with the Thermo Scientific™ QMS™ Everolimus Immunoassay.
Thermo Scientific™ CEDIA™ Mycophenolic Acid Immunoassays, Calibrators and Controls
Complete your ISD panel with the Thermo Scientific™ CEDIA™ Mycophenolic Acid Immunoassay.
Thermo Scientific™ CEDIA™ Therapeutic Drug Monitoring (TDM) Calibrators
Save time while maintaining accuracy with economical Thermo Scientific™ CEDIA™ Therapeutic Drug Monitoring (TDM) Calibrators, optimized for use with CEDIA TDM Assays.
Thermo Scientific™ QMS™ Therapeutic Drug Monitoring (TDM) Controls
Ensure accurate results when testing with the newest TDM reagents with Thermo Scientific™ QMS™ TDM Controls, offered in three levels.
Cayman Chemical MycophenolIc AcId 25mg
An immunosuppressive microbial metabolite; an active metabolite of mycophenolate mofetil; inhibits IMPDH type I and type II (IC50s = 32 and 11 nM, respectively, in cell-free assays); inhibits DNA synthesis in L strain mouse fibroblasts at 0.1-10 UG/ml; active against several strains of C. albicans, C. parakrusei, C. tropicalis, and C. neoformans (MICs = 3.9-31.25 UG/ml), as well as various strains of S. aureus (MICs = 31.25-125 UG/ml); reduces splenomegaly in a mouse model of Friend virus-induced leukemia at 150 mg/kg; decreases the number of hemolytic plaque forming cells isolated from the spleen of mice immunized with sheep RBCs at 60-240 mg/kg
AdipoGen Amikacin disulfate salt
Chemical. CAS 39831-55-5. Formula C22H43N5O13 . 2H2SO4. MW 781.76. Amikacin is a broad-spectrum aminoglycoside antibiotic and a semisynthetic analog of kanamycin. It irreversibly binds to 16S rRNA and the RNA-binding S12 protein of the 30S subunit and 50S subunit of prokaryotic ribosome and inhibits protein synthesis. It works in a concentration-dependent manner, and has better action in an alkaline environment. Amikacin disulfate is very active against most Gram-negative bacteria including gentamicin- and tobramycin-resistant strains, due to its resistance to inactivating enzymes. Amikacin disulfate also inhibits the infections caused by susceptible Nocardia and nontuberculous mycobacteria. Amikacin can be used to treat non-tubercular mycobacterial infections and tuberculosis when first-line drugs fail to control the infection.
Abcam Everolimus, mTOR inhibitor, 25MG
MW 958.2 Da, Purity >98%. Potent mTOR inhibitor (IC₅₀ = 1.6 - 2.4 nM). Immunosupressant and anticancer activity in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Everolimus, mTOR inhibitor, 5MG
MW 958.2 Da, Purity >98%. Potent mTOR inhibitor (IC₅₀ = 1.6 - 2.4 nM). Immunosupressant and anticancer activity in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
AdipoGen Amikacin disulfate salt
Chemical. CAS 39831-55-5. Formula C22H43N5O13 . 2H2SO4. MW 781.76. Amikacin is a broad-spectrum aminoglycoside antibiotic and a semisynthetic analog of kanamycin. It irreversibly binds to 16S rRNA and the RNA-binding S12 protein of the 30S subunit and 50S subunit of prokaryotic ribosome and inhibits protein synthesis. It works in a concentration-dependent manner, and has better action in an alkaline environment. Amikacin disulfate is very active against most Gram-negative bacteria including gentamicin- and tobramycin-resistant strains, due to its resistance to inactivating enzymes. Amikacin disulfate also inhibits the infections caused by susceptible Nocardia and nontuberculous mycobacteria. Amikacin can be used to treat non-tubercular mycobacterial infections and tuberculosis when first-line drugs fail to control the infection.
Cayman Chemical Mycophenolc ACD mthyl Ste 25mg
An esterified form of mycophenolic acid; inhibits pioglitazone-induced transactivation of PPARγ in U2OS cells in a reporter assay at 1 and 10 µM; cytotoxic against a panel of seven cancer cell lines (IC50s = 0.26-23.73 µM); inhibits tumor growth in an Ehrlich murine spontaneous adenocarcinoma model and decreases the production of antibodies against sheep red blood cells in mice at 120 mg/kg; has been used as a precursor in the synthesis of mycophenolic acid β-D-glucuronide; a potential impurity in commercial preparations of mycophenolate mofetil
Cayman Chemical Mycophenolc ACD mthyl Ste 50mg
An esterified form of mycophenolic acid; inhibits pioglitazone-induced transactivation of PPARγ in U2OS cells in a reporter assay at 1 and 10 µM; cytotoxic against a panel of seven cancer cell lines (IC50s = 0.26-23.73 µM); inhibits tumor growth in an Ehrlich murine spontaneous adenocarcinoma model and decreases the production of antibodies against sheep red blood cells in mice at 120 mg/kg; has been used as a precursor in the synthesis of mycophenolic acid β-D-glucuronide; a potential impurity in commercial preparations of mycophenolate mofetil
Cayman Chemical MycophenolIc AcId 100mg
An immunosuppressive microbial metabolite; an active metabolite of mycophenolate mofetil; inhibits IMPDH type I and type II (IC50s = 32 and 11 nM, respectively, in cell-free assays); inhibits DNA synthesis in L strain mouse fibroblasts at 0.1-10 UG/ml; active against several strains of C. albicans, C. parakrusei, C. tropicalis, and C. neoformans (MICs = 3.9-31.25 UG/ml), as well as various strains of S. aureus (MICs = 31.25-125 UG/ml); reduces splenomegaly in a mouse model of Friend virus-induced leukemia at 150 mg/kg; decreases the number of hemolytic plaque forming cells isolated from the spleen of mice immunized with sheep RBCs at 60-240 mg/kg
Cayman Chemical MycophenolIc AcId DGlucuro 5mg
A metabolite of mycophenolic acid; does not inhibit IMPDH type II in a cell-free assay; reduces tumor growth in an Ehrlich murine spontaneous adenocarcinoma model at 6 mg/animal